ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

220
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
372 Views
Share
02 Nov 2018 14:50

Japan: The Evolution Of (Non-Financial) Market Leadership

28 YEARS OF NON-FINANCIAL MARKET LEADERSHIP - To offer some light relief from the current market, we have compiled a graphic illustrating the...

Logo
413 Views
Share
31 Oct 2018 20:06

Takeda 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Notwithstanding brisk contribution by the key growth drivers including Entyvio (+33% to ~¥129b), Ninlaro (+36% to ~¥30b), Takecab...

01 Oct 2018 20:01

Takeda/Shire III : EGM Announced, Drug Deal Coming Together

Friday after the close, Takeda Pharmaceutical (4502 JP) announced that the company had established the Record Date for its EGM to approve its...

Logo
1.3k Views
Share
28 Sep 2018 18:05

Japan CAR-T Therapy Landscape

Japan CAR-T therapy - Competitive landscapeJapan pharma catching-up with global players… but a large gap remains Novartis AG (NOVN SE)’ Kymriah...

x